Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Pituitary Neoplasms 2Gastro-enteropancreatic neuroendocrine tumor 2Acromegaly 2Pancreatic Neoplasms 1Lymphoma, Follicular 1Growth Disorders 1Gigantism 1Carcinoid Tumor 1

Interventions

Octreotide 3lanreotide 2Everolimus 2pasireotide 1Sunitinib 1Serotonin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Carcinoid Tumor × pasireotide × Clear all
NCT00690430 2013-07-30

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

Novartis

Phase 3 Completed
186 enrolled 11 charts
Endocrine

Carcinoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡